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Abstract
Background: Musculoskeletal disorders of the elbow, forearm, wrist and hand are associated with pain, functional
impairment and decreased productivity in the general population. Combining several interventions in a multimodal
program of care is reflective of current clinical practice; however there is limited evidence to support its effectiveness. The
purpose of our review was to investigate the effectiveness of multimodal care for the management of musculoskeletal
disorders of the elbow, forearm, wrist and hand on self-rated recovery, functional recovery, or clinical outcomes in adults
or children.
Methods: We conducted a systematic review of the literature and best evidence synthesis. We searched MEDLINE,
EMBASE, CINAHL, PsycINFO, and the Cochrane Central Register of Controlled Trials from January 1990 to March 2015.
Randomized controlled trials, cohort studies, and case–control studies were eligible. Random pairs of independent
reviewers screened studies for relevance and critically appraised relevant studies using the Scottish Intercollegiate
Guidelines Network criteria. Studies with a low risk of bias were synthesized following best evidence synthesis principles.
Results: We screened 5989 articles, and critically appraised eleven articles. Of those, seven had a low risk of bias; one
addressed carpal tunnel syndrome and six addressed lateral epicondylitis. Our search did not identify any low risk of bias
studies examining the effectiveness of multimodal care for the management of other musculoskeletal disorders of the
elbow, forearm, wrist or hand. The evidence suggests that multimodal care for the management of lateral epicondylitis
may include education, exercise (strengthening, stretching, occupational exercise), manual therapy (manipulation) and
soft tissue therapy (massage). The evidence does not support the use of multimodal care for the management of carpal
tunnel syndrome.
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Conclusions: The current evidence on the effectiveness of multimodal care for musculoskeletal disorders of the elbow,
forearm, wrist and hand is limited. The available evidence suggests that there may be a role for multimodal care in the
management of patients with persistent lateral epicondylitis. Future research is needed to examine the effectiveness of
multimodal care and guide clinical practice.
Systematic review registration number: CRD42014009093
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Background
Musculoskeletal disorders, as defined by the Centers for
Disease Control and Prevention (CDC), are injuries or
disorders of the muscles, nerves, tendons, joints, cartil-
age and supporting structures of the upper and lower
limbs, neck and lower back [1]. These disorders may be
caused or exacerbated by exertion or prolonged expos-
ure to physical factors. Musculoskeletal disorders of the
elbow, forearm, wrist and hand commonly affect limb
function, social activities and the ability to work [2, 3].
In 2014, arm, wrist and hand injuries accounted for
12.0 % of lost time claims in Ontario workers [4].
Musculoskeletal disorders can occur in the supporting
ligaments and capsule of the humeroulnar, humerora-
dial, and proximal radioulnar joints of the elbow, as well
as the distal radioulnar, radiocarpal, intercarpal, midcar-
pal, carpometacarpal and intermetacarpal joints and may
involve the triangular fibrocartilage complex. They may
also involve tendons and muscles surrounding the
elbow, forearm, wrist, and hand. Injuries may also create
entrapment or other forms of distal neuropathies involv-
ing the median, ulnar or radial nerves.
Lateral epicondylitis is one of the most prevalent
disorders of the arm [5, 6] with a point prevalence of
1–3 % in the adult general population [2, 5, 7] and
up to 7.3 % in workers [3, 6, 8]. The incidence of lat-
eral epicondylitis is higher among females and peaks
between the ages of 40 and 50 years [9]. Lateral epi-
condylitis is a self-limiting condition with most cases
resolving within three months and up to 89 % of patients
report improvement in pain at one year [10, 11]. Recur-
rence has been reported in up to 8.5 % of cases [10]. Med-
ial epicondylitis is less common with a point prevalence of
0.4 % in adults [5] and 4.3 % in workers [6]. Medial epi-
condylitis is similarly a self-limiting condition with most
cases resolving within 6 to 12 months [12]. Ulnar neur-
opathy (cubital tunnel syndrome) at the elbow, is the
second most common upper extremity peripheral neur-
opathy [13, 14]. Ulnar neuropathy at the elbow has an
annual incidence of 24.7 cases per 100,000 person-years,
and is more common in men [14, 15]. Previous work sug-
gests that approximately one half of untreated mild ulnar
neuropathy report symptom resolution at one year [16],
with resolution of symptoms following non-surgical
interventions being inversely proportional to symptom
severity [17].
Carpal tunnel syndrome (CTS) is the most common
nerve entrapment neuropathy [18–20] with the point
prevalence ranging from 1.0 to 3.8 %, and is higher in fe-
males than males in the general population [7, 18, 21].
The point prevalence of CTS is higher in workers, ran-
ging from 2.2 to 14.0 % [8, 22–25]. Some CTS cases
resolve spontaneously, with initial low impairment sever-
ity associated with worsening of symptoms and severe
impairment associated with improvement [26]. Similarly,
the point prevalence of De Quervain’s tenosynovitis is
higher in females (1.3 %) than males (0.5 %) [7], and is
higher in workers than the general population [8, 23].
Elbow, forearm, wrist and hand musculoskeletal disor-
ders are associated with pain, functional impairment and
decreased productivity [2, 3, 5, 18, 21]. In Canada, lateral
epicondylitis is associated with lost productivity and in-
ability to work for up to eight weeks [5, 27]. The esti-
mated annual cost of medical care and lost work time
associated with lateral or medial epicondylitis in the
United States (US) is $22 billion (USD) [19]. In Alberta,
CTS was associated with 800 annual workers’ compensa-
tion claims during the time period 1998 to 2002 [28].
Although, average lost work days decreased (151 to 98)
between 1998 and 2002 carpal tunnel surgeries increased
during this period [28]. With approximately 400,000 car-
pal tunnel surgeries performed annually at a cost of $2
billion (USD), surgery for CTS is not only the most
common but also the most costly upper extremity dis-
order treatment in the US [21, 29].
Clinicians manage patients’ conditions according to
their training, beliefs, preferences and understanding of
the evidence. Moreover, clinicians are likely to combine
various interventions recognized as multimodal care
when managing patients’ conditions. However, random-
ized control trials (RCTs) commonly examine the effect-
iveness of single interventions which has limited
applicability to clinical practice [30]. Therefore, under-
standing the effectiveness of multimodal care is import-
ant to guide clinical practice and provide the best
available care to patients.
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To our knowledge, no systematic review has evalu-
ated the effectiveness of multimodal care for the
management of musculoskeletal disorders of the
elbow, forearm, wrist and hand. The objective of our
systematic review was to examine the effectiveness of
multimodal care for the management of musculoskel-
etal disorders of the elbow, forearm, wrist and hand
on self-rated recovery, functional recovery or clinical
outcomes in adults or children.
Methods
Registration of review
This review protocol was registered with the Inter-
national Prospective Register of Systematic Reviews
(PROSPERO) on January 31st, 2014 (CRD42014009093).
Eligibility criteria
Population
We included studies of children and adults eighteen
years and older diagnosed with musculoskeletal disor-
ders of the elbow, forearm, wrist and hand, including
non-specific elbow, forearm, wrist and hand pain, olecra-
non bursitis, lateral epicondylitis (tennis elbow), medial
epicondylitis (golfer’s elbow), ulnar neuropathy (cubital
tunnel syndrome), carpal tunnel syndrome, De Quervain’s
tenosynovitis, and other musculoskeletal disorders of the
elbow, forearm, wrist and hand as informed by available
evidence [31]. Study participants who had been clinically
diagnosed by a health care professional within their de-
fined scope of practice, were considered for inclusion in
our review. Grades I and II sprains or strains of the elbow,
forearm, wrist and hand were included in our review. We
excluded studies of elbow, forearm, wrist or hand injuries
due to major structural pathology (e.g., fractures, disloca-
tions, amputations, open wounds, tears of surrounding
structures, osteoarthritis, spinal cord injury or neoplasms).
We defined sprains and strains according to the definition
proposed by the American Academy of Orthopaedic
Surgeons [32–34].
Interventions
We defined multimodal care as a treatment approach
that includes at least two distinct therapeutic modal-
ities, provided by one or more health care disciplines
[35]. Therapeutic modalities included: acupuncture,
education, exercise, manual therapy (manipulation,
mobilization, traction), passive physical modalities
(e.g., heat application, cryotherapy, ultrasound, splints,
braces), prescribed medication (e.g., acetaminophen,
non-steroidal anti-inflammatory drugs), psychological
interventions (e.g., relaxation, biofeedback) and soft-tissue
therapies (e.g., massage, muscle energy technique). We
excluded studies where the effectiveness of a single inter-
vention could be isolated. For example, if supervised
exercise plus an orthosis were compared to an orthosis
alone, the effect of supervised exercise could be isolated
and the study would not be considered in the analysis of
multimodal care.
Comparison groups
Studies that compared multimodal care to other inter-
ventions, placebo/sham interventions or no intervention
were considered.
Outcomes
Eligible studies included: 1) self-rated recovery; 2) func-
tional recovery (e.g., return to activities at work or
school); 3) disability; 4) pain intensity; 5) health-related
quality of life; 6) psychological outcomes (e.g., depres-
sion, fear); or 7) adverse events.
Study characteristics
Eligible studies met the following criteria: 1) English lan-
guage; 2) published between January 1st, 1990 and
March 12th, 2015; 3) RCTs, cohort studies, or case–con-
trol studies; and 4) included an inception cohort of at
least 30 participants per treatment arm with the speci-
fied condition for RCTs, or 100 subjects per treatment
arm in cohort studies or case–control studies. We con-
sidered cohort studies to ensure that all designs that
may be used to examine study effectiveness and safety
were included in our review. A low risk of bias cohort
study may provide a higher level of evidence than a high
risk of bias RCT [36–38]. This implies that the investiga-
tors of a high-quality cohort study have addressed the
potential for confounding by indication. Evidence from
well conducted case–control studies is valuable in un-
derstanding the risk of adverse events associated with
specific treatments and are therefore included in this
systematic review. Study exclusion criteria included: 1)
letters, editorials, commentaries, unpublished manu-
scripts, dissertations, government reports, books and
book chapters, conference proceedings, meeting ab-
stracts, lectures and addresses, consensus development
statements, or guideline statements; 2) pilot studies,
cross-sectional studies, case reports, case series, qualita-
tive studies, narrative reviews, systematic reviews,
clinical practice guidelines, biomechanical studies, or
laboratory studies; or 3) cadaveric or animal studies.
Data sources and searches
Our search strategy was developed in consultation with
a health sciences librarian, and a second librarian
reviewed the search for completeness and accuracy using
the Peer Review of Electronic Search Strategies (PRESS)
Checklist [39, 40]. We searched MEDLINE and
EMBASE, considered to be the major biomedical data-
bases, and PsycINFO for psychological literature,
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through Ovid Technologies, Inc.; CINAHL Plus with
Full Text for the nursing and allied health literature
through EBSCO host; and the Cochrane Central
Register of Controlled Trials, through Ovid Technolo-
gies, Inc. for any studies not captured by other data-
bases. Searches were conducted from January 1st,
1990 to March 12th, 2015.
The search strategy was first developed in MEDLINE
and subsequently adapted to the other databases. The
search terms included subject headings specific to each
database (e.g., MeSH in MEDLINE) [41] and free text
words relevant to multimodal care and musculoskeletal
disorders of the elbow, forearm, wrist and hand, includ-
ing sprains and strains grades I-II (Additional file 1).
Databases containing the results of the searches were
created using EndNote X6 [42].
Study selection
Eligible studies were selected through a two-phase
screening process. In phase one, two randomly paired
reviewers independently screened titles and abstracts to
determine eligibility. Studies were classified as relevant,
possibly relevant or irrelevant. In phase two, the same
reviewers independently reviewed manuscripts of pos-
sibly relevant studies to make a final determination of
eligibility. Reviewers met to resolve disagreements and
reach consensus in both phases. We involved a third
independent reviewer if consensus could not be reached.
Quality assessment and data extraction
Independent reviewer pairs critically appraised the in-
ternal validity of eligible studies using the Scottish Inter-
collegiate Guidelines Network (SIGN) criteria for RCTs,
cohort studies and case–control studies [43]. The SIGN
criteria assist with the evaluation of the impact of selec-
tion bias, information bias, and confounding on the
results of a study. We did not use a quantitative score or
a cutoff point to determine the internal validity of stud-
ies [44]. Rather, the SIGN criteria were used to assist
reviewers in making an informed overall judgment on
the internal validity of studies. This methodology has
been previously described [45–48].
Specifically, we critically appraised the following meth-
odological aspects of the studies: 1) clarity of the research
question; 2) randomization method; 3) concealment of
treatment allocation; 4) blinding of treatment and out-
comes; 5) similarity of baseline characteristics between
treatment arms; 6) co-intervention/contamination; 7)
validity and reliability of outcome measures; 8) attrition;
9) intention to treat analysis; and 10) comparability of
results across study sites (where applicable). A study was
considered to have a high risk of bias if reviewers consid-
ered that the study’s internal validity was compromised as
a result of biases and methodological flaws, including: a) a
RCT with an inadequate randomization method and/or
without clear concealment of treatment allocation, and
with non-random distribution of baseline characteristics
which were not controlled for in the analysis; b) unex-
plained high or differential attrition rates; c) absence of an
intention to treat analysis in order to provide a conserva-
tive estimate of therapeutic effect; or, d) outcome
measures without established validity and reliability.
Moreover, inadequate blinding, an imbalance of co-
interventions and lack of comparability across treatment
sites (if applicable) were considered as additional limita-
tions. All reviewers were trained in the evaluation of stud-
ies using the SIGN criteria. Consensus between reviewers
was reached through discussion. An independent third
reviewer was used to resolve disagreements if consensus
could not be reached. We contacted authors when
additional information was needed to complete the critical
appraisal. Studies with a low risk of bias were included in
our evidence synthesis [49].
The lead author extracted data from studies with a
low risk of bias into evidence tables. A second reviewer
independently checked the extracted data. Meta-analysis
was not performed due to heterogeneity of studies with
low risk of bias.
Data synthesis and analysis
A qualitative synthesis of the low risk of bias studies was
performed according to principles of best evidence syn-
thesis [49]. We stratified our synthesis according to
disorder type and duration [i.e., recent (<3 months), per-
sistent (≥3 months)]. We further stratified the multi-
modal programs of care according to their effectiveness
to determine the components of intervention that are
associated with superior outcomes: 1) superior (associ-
ated with a minimal clinically important difference
(MCID) compared to its comparator) [50]; 2) equivalent
(no clinically important differences between groups);
and 3) inferior (associated with worse outcomes than its
comparator). The following MCID thresholds were
employed: Carpal Tunnel Syndrome Assessment Ques-
tionnaire (CTSAQ)-Symptom Severity Scale (SSS) 0.16/5
[51], and Functional Status Scale (FSS) 0.47/5 [51]; 14/
100 mm on the visual analogue scale (VAS) [52]; 2/10
difference on the Numeric Rating Scale (NRS) [53]; 11/
100 or 37 % of baseline score for the Patient-rated
Tennis Elbow Evaluation (PRTEE) [54]; and 6.5 kg
(19.5 %) for grip strength [55]. We estimated the inten-
sity of care by computing the mean number of visits and
treatment duration for superior outcomes associated
with each disorder type.
Statistical analyses
The inter-rater agreement for article screening was com-
puted using the kappa coefficient (ĸ) and 95 %
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confidence intervals (CI) [56, 57]. The percentage agree-
ment for critical appraisal was calculated for low and
high risk of bias studies. Similarly, we computed the dif-
ference in mean change between groups and its 95 % CI
to quantify effect sizes. The computation of the 95 % CI
for the difference in mean change assumed that the pre-
and post-intervention outcomes were highly correlated
(r = 0.8) [58, 59].
Reporting
The systematic review was organized and reported based
on the Preferred Reporting Items for Systematic Reviews
and Meta-Analyses (PRISMA) statement [60].
Results
Study selection
Our search yielded 8050 articles. We removed 2066
duplicates and screened 5989 articles (Fig. 1). Of those,
11 articles (reporting on ten studies) were eligible for
critical appraisal and seven articles (six studies) had a low
risk of bias and were included in our synthesis [61–67].
During critical appraisal of articles we contacted the au-
thors of five studies for further information and clarifica-
tion [61, 64, 65, 68, 69] and three responded [61, 65, 69].
The inter-rater agreement for the screening of articles
was ĸ = 0.84 (95 % CI 0.67; 1.00). The percentage agree-
ment for the critical appraisal of articles was 90.9 % (10/11
articles). For the study where reviewers disagreed, consen-
sus was reached through discussion. The two reviewers
met and reviewed each methodological criterion using a
standardized approach (SIGN criteria), ensuring that a
comprehensive analysis of the potential sources of selec-
tion and information bias, as well as confounding, and
their impact on the study were discussed. A final consen-
sus judgment on the quality of the study was then deter-
mined by both reviewers.
Fig. 1 Identification and selection of articles
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Study characteristics
All six studies (seven articles) with low risk of bias were
RCTs. One study addressed CTS [61], and five studies
(six articles) examined lateral epicondylitis [62–67].
There was a range of interventions reported in the
multimodal programs of care including: education, exer-
cise, manual therapy (manipulation), soft-tissue therapy
(deep friction massage); passive physical modalities
(ultrasound, splints), prescribed medication and usual
physician care (Tables 1 and 2). Exercise (5/5), education
(3/5) and soft tissue therapy (3/5) were the most com-
mon interventions included in a multimodal program of
care for the management of lateral epicondylitis. Two
health care disciplines were identified in the delivery of
multimodal programs of care for CTS (hand therapist,
general practitioner), and three for lateral epicondylitis
(physical therapist, general practitioner, ergonomist).
Two studies, one for the management of CTS [61] and
one for lateral epicondylitis included more than one
health care discipline to deliver a single multimodal care
intervention [64].
Risk of bias within studies
All RCTs with a low risk of bias used appropriate
randomization procedures, valid and reliable outcome
measures and performed an intention-to-treat analysis
(Table 3) [61–67]. The follow-up rate was above 85 %
for all but one RCT [61–63, 65–67]. The study by Haahr
et al. reported follow-up rates above 75 % [64]. However,
the studies with a low risk of bias had some limitations
including: 1) differences in baseline characteristics (2/6)
[64, 66]; and 2) no description of co-interventions (3/6)
[62–66].
Four studies had high risk of bias [69–72]. The meth-
odological weaknesses of the three RCTs include: inad-
equate description of randomization (3/3) [70–72];
blinding of treatment and outcome assessment not
described (3/3) [70–72]; no information regarding co-
interventions (3/3) [70–72]; valid and reliable outcome
measures not used (2/3) [70, 72]; and intention to treat
analyses not used (3/3). The fourth study was a cohort
study which did not adequately describe the source
population; baseline characteristics of the sample were
not described; and potential confounders were not
adjusted for in the analysis [69].
Summary of evidence
Carpal tunnel syndrome of persistent duration
Evidence from one RCT suggests that multimodal care
provided by a physician and a hand therapist is less
effective than decompression surgery and hand ther-
apy for the management of carpal tunnel syndrome
(Table 4) [61]. In their trial Jarvik et al. [61] random-
ized participants to: 1) multimodal care that included
a combination of non-steroidal anti-inflammatory drugs,
an education booklet, exercise, stretching, splint (night
and as tolerated by day), ultrasound and home/workplace
modifications; 2) open or endoscopic decompression sur-
gery followed by hand therapy (median nerve and tendon
gliding exercises). Compared with multimodal care,
surgery plus hand therapy led to statistically but non-
clinically important improvement in functional status
(Boston Carpal Tunnel Syndrome Questionnaire) at six
(mean change difference -0.46/5 (95 % CI -0.72; -0.20))
and twelve months (mean change difference -0.40/5
(95 % CI -0.70; -0.11)). Surgery was associated with
statistically and clinically important differences in the
secondary outcome-severity of symptoms (Boston
Carpal Tunnel Syndrome Questionnaire) at six (mean
change difference -0.42/5 (95 % CI -0.77; -0.07)) and
twelve months (mean change difference -0.34/5 (95 %
CI -0.65; -0.02)). The authors reported no differences
in other secondary outcomes.
Lateral epicondylitis of persistent duration
Multimodal care compared to corticosteroid injection
Evidence from one RCT suggests that multimodal care
by a physical therapist provides long term benefits com-
pared to corticosteroid injection plus education by a
physician, and offers similar outcomes to reassurance
and advice by a physician (Table 5) [62, 63]. In their
RCT, Bisset et al. [62, 63] randomized participants to: 1)
multimodal care (manipulation, clinic and home based
exercise) provided in eight sessions over six weeks; 2)
corticosteroid injection of the painful elbow joint and
advice to return to normal activities (a second injection
was offered after two weeks if necessary); or 3) reassur-
ance and advice on self-management (activity modifica-
tion; analgesic drugs, heat, cold or braces as needed). All
participants received an information booklet covering
the disease process, self-management, and ergonomics.
Participants who received the corticosteroid injection
demonstrated greater improvement in pain (mean
change difference -15.8/100 (99 % CI -26.4; -5.1)) and
were more likely to report self-perceived improvement
(RR 0.79 (99 % CI 0.63; 0.99)) at six weeks post-
intervention; however, those in the multimodal care
group were more likely to report self-perceived improve-
ment (RR 1.32 (99 % CI 1.09; 1.59)) and greater pain re-
duction (mean change difference 14.5/100 (99 % CI 4.2;
24.8)) at 52 weeks. Multimodal care participants were
less likely to experience a recurrence than the cortico-
steroid injection group (RR 0.11 (95 % CI 0.05; 0.25)).
Participants receiving multimodal care reported clinic-
ally important improvement in pain (mean change
difference 15.6/100 (99 % CI 7.3; 22.8)) at six weeks but
not 52 weeks compared to the reassurance and advice
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Manipulation Mobilisation Traction Ultrasound Splint Heat/Cold
Bisset [62, 63] PTc 8 6 ✓ ✓ ✓
GPe 2 6 ✓ ✓
GPd 1 6 ✓
Smidt [66] PTc 9 6 ✓ ✓ ✓
GPe 3 6 ✓
GPd 1 6 ✓ ✓
Haahr [64] GP, Ergonomistd 1 UK ✓ ✓ ✓
GPd 1 UK ✓
Nagrale [65] PTc 12 4 ✓ ✓ ✓
PTe 12 4 ✓ ✓ ✓
Struijs [67] PTd 9 6 ✓ ✓ ✓
PTd 1 6 ✓
PTd 9 6 ✓ ✓ ✓ ✓
aEmpty cells indicate that the intervention component was not provided in the treatment arm
bTable includes only modalities reported in scientifically admissible studies
Acronyms: GP general practitioner, PT physical therapist, UK unknown












Table 2 Combinations of Interventions in Multimodal Care for Carpal Tunnel Syndrome Reported in Scientifically Admissible Randomized Controlled Trials, 1990–2015a,b
Education Exercise Manual Therapy Soft Tissue Therapy Acupuncture Passive Modalities Surgery




Manipulation Mobilisation Traction Ultrasound Splint
Jarvik [61] GP, HTc 30 12 ✓ ✓ ✓ ✓
Surgeon, HTd UK UK ✓ ✓
aEmpty cells indicate that the intervention component was not provided in the treatment arm
bTable includes only modalities reported in scientifically admissible studies
Acronyms: GP general practitioner, HT hand therapist












Table 3 Risk of Bias for Accepted Randomized Controlled Trials based on the Scottish Intercollegiate Guidelines Network (SIGN) Criteria [43]
Author, Year Research
Question










Bisset et al., 2006, 2009 [62, 63] Y Y Y Y Y N Y 6 Weeks:
Multimodal Care: 5 %
Corticosteroid
Injection: 0 %
Reassurance and advice: 10 %
52 Weeks:
Multimodal Care: 5 %
Corticosteroid Injection: 0 %
Reassurance and advice: 7 %
Y CS
Haahr et al., 2003 [64] Y Y Y Y N N Y 3 Months:
Multimodal GP/Ergonomist: 16 %
GP: 14 %
6 Months:
Multimodal GP/Ergonomist: 19 %
GP: 16 %
12 Months:
Multimodal GP/Ergonomist: 22 %
GP: 18 %
Y CS
Jarvik et al., 2009 [61] Y Y Y Y Y Y Y 12 Months:
Multimodal Care: 11.9 %
Surgery: 14.0 %
Y Y
Nagrale et al., 2009 [65] Y Y Y Y Y N Y No drop outs NA CS
Smidt et al., 2002 [66] Y Y Y CS N N Y Multimodal PT: no drop outs
Reassurance and advice: no drop outs
Corticosteroid injection:
12 weeks: 1.6 %
26 weeks: 1.6 %
Y CS
Struijs et al., 2004 [67] Y Y CS Y Y Y Y 6 Weeks:
Multimodal PT: 3.6 %
Brace: 1.5 %
Multimodal PT + Brace: 1.8 %
26 Weeks:
Multimodal PT: 3.6 %
Brace: 5.9 %
Multimodal PT + Brace: 3.6 %
52 Weeks:
Multimodal PT: 5.4 %
Brace: 5.4 %
Multimodal PT + Brace: 3.6 %
Y NA












Table 4 Evidence table for accepted randomized control trials on multimodal care and carpal tunnel syndrome
Author(s), Year Subjects and Setting;
Number (n) Enrolled




Follow-up Outcomes Key Findings
Jarvik et al., 2009 [61] Participants (≥18 y.o.)
recruited from Washington
State and New Hampshire.
Case definition:
symptoms ≥2 weeks in at
least 2 digits including
thumb, index, ring finger;





pain waking; positive flick
test. (n = 116).
Multimodal Care by physician
and hand therapist: NSAIDS
(ibuprofen 200 mg/3x /day),
opioid, corticosteroid; hand
therapy (6 visits/6 weeks):
educational booklet, exercises,
stretching, tendon gliding,
wrist splint and work/activity
modifications; ultrasound if
no improvement 6 weeks
after randomization (maximum
12 15-min sessions; 2–4 per
week/6 weeks): 1Mhz, 1.0
W/cm2 in 1:4 pulsed mode.
(n = 59)
Surgery: open or endoscopic
decompression, followed by
hand therapy (median nerve











intensity (NRS 0–10); hand/
wrist pain interference (NRS
0–10); work days lost (0–28);
limited activity days; general






symptom severity; and a
score of 0 or 1 on hand/
wrist pain interference with
work or housework
Adverse events.
*Difference in Mean Change Score
(Multimodal Care-Surgery)
CTSAQ Function
6 months: -0.46 (95 % CI -0.72; -0.20)
12 months: -0.40 (95 % CI -0.70; -0.11)
CTSAQ Symptom Severity
6 months: -0.42 (95 % CI -0.77; -0.07)
12 months: -0.34 (95 % CI -0.65; -0.02)
There were no clinically or statistically
differences between groups in days
of reduced work/housework, work
days lost, pain intensity, pain
interference or SF-36 at any follow-up
point.
Successful Outcomea
6 months: Multimodal Care: RR 0.51
(95 % CI 0.25; 1.05)
12 months: Multimodal Care: RR 0.62
(95 % CI 0.35; 1.08)
Adverse Events: No clinically
important adverse events; no surgical
complications.
aCalculated by OPTIMa team (Follman (1992); Abrams (2005))
*ANCOVA adjusted for baseline value of the outcome measure and treatment site












Table 5 Evidence table for accepted randomized controlled trials on multimodal care and lateral epicondylitis






Follow-up Outcomes Key Findings






with palpation of the
lateral epicondyle,
gripping, resisted wrist
or second or third
finger extension of >6
weeks duration.(n = 198)
Multimodal care by a










by a GP (1 ml 1 %
lidocaine with 10 mg
triamcinolone acetonide
in 1 ml); 1 injection at
painful points and
second injection after













booklet (disease process, self
management advice,
ergonomics) (n = 67)






















Relative Risk (Multimodal Care vs.
Corticosteroid Injection):a
Success
6 weeks: RR 0.79 (95 % CI 0.63; 0.99)
12 weeks: RR 1.53 (95 % CI 1.11; 2.10)
26 weeks: RR 1.73 (95 % CI 1.28; 2.34)
52 weeks: RR 1.32 (95 % CI 1.09; 1.59)
Recurrence
After 6 weeks: RR 0.11 (95 % CI 0.05;
0.25)
Difference in Mean Change from
Baseline: (Multimodal Care -
Corticosteroid Injectionb)
Pain-free Grip Force
6 weeks:–17.4 (99 % CI -22.4; -12.4)
12 weeks: 13.1 (99 % CI 7.6; 18.6)
26 weeks: 28.2 (99 % CI 21.6; 34.8)
52 weeks: 12.3 (99 % CI 6.7; 17.9)
Pain Severity
6 weeks: -13.4 (99 % CI -18.8; -8.0)
12 weeks: 19.4 (99 % CI 13.6; 25.2)
26 weeks: 20.0 (99 % CI 14.6; 25.4)
52 weeks: 18.2 (99 % CI 12.6; 23.8)
PFFQ
6 weeks: -20.3 (99 % CI -26.9; -13.6)
12 weeks: 12.4 (99 % CI 5.1; 19.7)
26 weeks: 21.4 (99 % CI 15.1; 27.6)
52 weeks: 18.8 (99 % CI 11.9; 25.7)
Sensorimotor Function
There were no clinical or statistical
differences between groups in
SRT, RT1, RT2, S1 or S2 at any
follow-up point.
Relative Risk Reduction (Multimodal
Care vs. Reassurance and Advice):a
Success
6 weeks: RR 2.60 (99 % CI 1.63; 4.15)
12 weeks: RR 1.31 (99 % CI 0.98; 1.73)
26 weeks: RR 1.08 (99 % CI 0.88; 1.32)
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Recurrence
6 weeks: RR 0.85 (95 % CI 0.27; 2.65)
Difference in Mean Change from
Baseline (Multimodal care –
Reassurance and Adviceb):
Pain-free Grip Force
6 weeks: 24.0 (99 % CI 19.0; 29.0)
12 weeks: 14.3 (99 % CI 9.5; 19.1)
26 weeks: 15.4 (99 % CI 9.9; 20.9)
52 weeks: 10.0 (99 % CI 4.4; 15.6)
Pain Severity
6 weeks: 12.2 (99 % CI 7.3; 17.1)
12 weeks: 5.8 (99 % CI 0.8; 10.8)
26 weeks: 4.9 (99 % CI -0.5; 10.3)
52 weeks 1.4 (99 % CI -4.2; 7.0)
PFFQ
6 weeks: 15.7 (99 % CI 9.9; 21.5)
12 weeks: 17.4 (99 % CI 11.2; 23.6)
26 weeks: 5.0 (99 % CI -1.1; 11.1)
52 weeks: 10.4 (99 % CI 4.1; 16.7)
Sensorimotor Function
There were no clinical or statistical
differences between groups in SRT,
RT1, RT2, S1 or S2 at any follow-up
point.
Adverse Events
Minor: pain following treatment,
loss of skin pigment; subcutaneous
tissue atrophy. Multimodal Care:
10.6 %; Corticosteroid Injection:
20.0 %; Wait and See: 0.0 %.
Haahr et al., 2003 [64] Adults (18–66 y.o.) with
lateral epicondylitis




episode (<1 year) of
lateral epicondylitis (i.e.,
indirect tenderness at















Usual care provided by
GP. (n = 141)
1 year Primary Outcome:Self-
reported overall
development of condition
(5 point Likert; ‘much
better’ to ‘much worse’);





or changed job, start
education or rehabilitation
Perceived unchanged or worse
overall developmentc:Control:
OR 1.0
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extension of wrist and/
or third finger (n = 289).
ergonomist. OTC
analgesics, (n = 148)
activity, labour
compensation claim.






























4 and 8 weeks Primary Outcome: pain





Cyriax Physiotherapy – Phonophoresis











Smidt et al., 2002 [66] Primary care setting (85
family doctors), referred




duration (n = 185)
Multimodal Care:









(1 mL of 10 mg/mL
triamcinolone
cetonide + 1 mL 2 %
lignocaine) at each
tender spot; maximum
3 injections in 6 weeks,
avoid pain-provoking
activities provided by
family doctor(n = 62)
Reassurance and
Advice: 1 visit with







improvement (n = 59)





worse”); success = “
completely recovered” or
“much improved”; severity
of main complaint (NRS









grip strength (kg); pressure
pain threshold; satisfaction
with intervention.
All scales transformed to
0–100.
Adverse events.
Multimodal Care – Reassurance and
Advice
Difference in Mean Change Score a
Success rate
6 weeks:
RR 1.46 (95 % CI 0.93; 2.29)
52 weeks:RR 1.09 (95 % CI 0.95; 1.25)
Multimodal Care - Corticosteroid
injection
Success rate
6 weeks: RR 0.51 (95 % CI 0.39; 0.67)
52 weeks: RR 1.31 (95 % CI 1.09; 1.57)
Adverse events: increased pain;
radiating pain; facial flush; skin
irritation; red swollen elbow; skin
colour change; other minor or
temporary adverse reactions.
Multimodal: 64 %; Corticosteroid
Injection:58 %; Reassurance and
Advice: 17 %
Struijs et al., 2004 [73] Patients referred from
GP and primary care


























worse”); success = “
completely recovered” or
“much improved”; severity
of complaints (0–11 NRS);
Multimodal Care – Brace
Success rate
6 weeks: RR 1.22 (95 % CI 0.9; 1.7)
26 weeks: RR 0.89 (95 % CI 0.5; 1.6)
52 weeks: RR 1.26 (95 % CI 0.5; 3.3)



















pain intensity of most
severe complaint (0–11












transformed to 100 point
scale.
Severity of Complaints
6 weeks: 5 (95 % CI -2; 12)
52 weeks: -1 (95 % CI -10; 5)
Pain Intensity
6 weeks: 13 (95 % CI 3; 21)
26 weeks: -1 (95 % CI -12; 10)
52 weeks: 0 (95 % CI -10; 11)
PFFQ
6 weeks: 7 (95 % CI 1; 12)
26 weeks: 0 (95 % CI -6; 7)
52 weeks: -3 (95 % CI -9; 3)
There were no clinical or statistical
differences between groups in
inconvenience during daily activities,
pain-free grip strength, maximum
grip strength or pressure pain
threshold at any follow-up point.
Satisfaction
6 weeks: 9 (95 % CI 1, 18)
Multimodal Care – Combination
Success rate
6 weeks: RR 0.90 (95 % CI 0.6; 1.3)
26 weeks: RR 1.31 (95 % CI 0.7; 2.4)
52 weeks: RR 0.87 (95 % CI 0.3; 2.4)
Difference in Mean Change Score
Severity of Complaints
6 weeks: -6 (95 % CI -12; 1)
52 weeks: -3 (95 % CI -11; 4)
Pain Intensity
6 weeks: 7 (95 % CI -4; 17)
26 weeks: -4 (95 % CI -14; 7)
52 weeks: 2 (95 % CI -8; 13)
PFFQ6 weeks: -2 (95 % CI -8; 4)
26 weeks: -6 (95 % CI -12; 1)
52 weeks: -5 (95 % CI -12; 1)
There were no clinical or statistical
differences between groups in
inconvenience during daily
activities, pain-free grip strength,
maximum grip strength or












Table 5 Evidence table for accepted randomized controlled trials on multimodal care and lateral epicondylitis (Continued)
Pressure pain threshold
6 weeks: −13 (95 % CI −25; −1)
Combination–Brace
Success rate
6 weeks: RR 1.11 (95 % CI 0.8; 1.5)
26 weeks: RR 1.17 (95 % CI 0.6; 2.2)
52 weeks: RR 1.10 (95 % CI 0.4; 2.8)
Difference in Mean Change Score
Severity of Complaints
6 weeks: 11 (95 % CI 6; 18)
52 weeks: 1 (95 % CI −6; 8)
Pain Intensity
6 weeks: 6 (95 % CI −15; 4)
26 weeks: 5 (95 % CI −7; 17)
52 weeks: −2 (95 % CI −12; 8)
PFFQ
6 weeks: 9 (95 % CI 2; 15)
26 weeks: 6 (95 % CI −1; 13)
52 weeks: 2 (95 % CI −5; 9)
There were no clinical or statistical
differences between groups in
inconvenience during daily
activities, pain-free grip strength,
maximum grip strength or
pressure pain threshold at any
follow-up point.
Satisfaction
6 weeks: 11 (95 % CI 3; 19)
aCalculated by OPTIMa team [58, 59]
bAdjusted for baseline value of outcome measure and demographic characteristics
c:Adjusted for gender, age, education, BMI, physical activity, physical strain at work, social support at work, pain in shoulder or forearm/hand past 3 months, baseline distress, baseline pain, tennis elbow on
dominant side
d:P < 0.05, CI not provided
Acronyms: CI Confidence Interval, CTSAQ Carpal Tunnel Syndrome Assessment Questionnaire, GP general practitioner, GRC Global Rating of Change, OR Odds Ratio, PFFQ Pain Free Function Questionnaire, PRTEE
Patient-rated Tennis Elbow Evaluation, PT physiotherapy, RR Relative Risk, RT1 1-choice reaction time, RT2 2-choice reaction time, S1 1-choice speed of movement, S2 2-choice speed of movement, SRT Simple Reaction












group. Those in the multimodal care group were more
likely to report self-perceived improvement than those
in the reassurance and advice group (RR 2.60 (99 % CI
1.63; 4.15)) at 6 weeks, but not at 52 weeks. However,
the proportion of patients reporting self-perceived im-
provement is higher in the multimodal care group at
each follow-up point compared to the reassurance and
advice group. It is not until 26 weeks that the reassur-
ance and advice group report a similar proportion of
global improvement as the multimodal care group
reported at six weeks. Although the probability of self-
perceived improvement is similar at 52 weeks, the multi-
modal care group reports positive sustained outcomes at
a much earlier time point compared to the reassurance
and advice group.
Evidence from a second RCT suggests that multimodal
care by a physical therapist provides long term benefits
compared to corticosteroid injection and advice by a
general practitioner (GP), but offers similar outcomes to
reassurance and advice (Table 5) [66]. In their RCT,
Smidt et al. [66] randomized participants to: 1) multi-
modal care (pulsed ultrasound, deep friction massage
and an exercise program) provided in nine sessions over
six weeks; 2) corticosteroid injection delivered to tender
spots (maximum three injections over six weeks) and
advice to avoid pain provoking activities; or 3) re-
assurance and advice (reassurance, avoid activities
that provoke pain; ergonomic advice; paracetamol or
non-steroidal anti-inflammatory drugs). Participants
allocated to multimodal care were less likely to report
self-perceived improvement at six weeks (short term)
(RR 0.51 (95 % CI 0.39; 0.67)), but more likely to
report improvement at 52 weeks (RR 1.31 (95 % CI
1.09; 1.57)) than those who received the corticosteroid
injection. No differences were found between partici-
pants allocated to multimodal care and those in the
reassurance and advice group.
Multimodal care compared to other interventions
Evidence from one RCT suggests that multimodal care
provided by a general practitioner and ergonomist leads
to similar outcomes as usual care offered by a GP for
the management of lateral epicondylitis (Table 5) [64].
Haahr et al. [64] randomized participants to multimodal
care (advice against complete rest, stay active, avoid
activities which exaggerate pain, graded exercise, analge-
sics, “elbow bandages”) by a GP and ergonomist or usual
GP care. The authors found no difference between
groups in perceived change of condition (OR 1.0 (95 %
CI 0.4; 2.3)) at one year follow-up.
Evidence from one RCT suggests that multimodal care
including Cyriax physiotherapy may offer greater benefit
than multimodal care including phonophoresis for the
management of lateral epicondylitis (Table 5) [65]. In
their RCT, Nagrale et al. [65] randomized participants
to: 1) Cyriax physiotherapy (deep transverse friction
massage, Mill’s manipulation); or 2) phonophoresis, with
Voveran Emulgel, over the lateral epicondyle, and super-
vised exercise (static stretching, eccentric strengthening).
All participants received education (ergonomics, activity
modification) to avoid provoking symptoms and remain
active, each provided in 12 visits over four weeks. Partic-
ipants who received Cyriax physiotherapy reported sta-
tistically and clinically important improvement in pain
severity at four (mean change difference 1.8) and six
weeks (mean change difference 2.5) (95 % CI data not
provided; p < 0.05). The Cyriax physiotherapy group re-
ported greater improvement in grip strength and the
Tennis Elbow Function Scale at both time points (p <
0.05), however the clinical importance of these outcomes
are not known.
Evidence from one RCT suggests that multimodal care
and an elbow brace in combination or as separate inde-
pendent treatments provided by a physical therapist had
similar outcomes (Table 5) [67]. In their RCT, Struijs et
al. [67] randomized participants to: 1) multimodal care
(pulsed ultrasound, friction massage, clinic and home
exercise program); 2) elbow brace worn continuously for
six weeks over the common extensor tendon; or 3) a
combination of the above. There were statistically sig-
nificant short-term differences (six weeks) favouring
multimodal care (pain intensity, Pain Free Function
Questionnaire (PFFQ)) and combined therapy (severity
of complaints, PFFQ) over brace alone. However, these
differences were not clinically important. No statistically
significant or clinically important differences were found
at 26 or 52 weeks.
Components of effective multimodal programs of care
The multimodal programs of care that benefited lateral
epicondylitis included education, exercise (strengthen-
ing, stretching, occupational exercises), manual therapy
(manipulation) and soft tissue therapy (deep friction
massage) (Table 5) [62, 63, 65, 66]. An average of 5 visits
(range 3 to 12) offered over five weeks (range 4 to
6 weeks) was associated with superior outcomes for the
management of lateral epicondylitis.
Adverse events
Three studies reported on adverse events and all were
mild and transient [61–63, 66]. Jarvik et al. indicated
that there were no clinically important adverse events
and there were no surgical complications [61]. Bisset et
al. reported that the greatest number of adverse events
were associated with corticosteroid injection (20.0 %)
compared to multimodal care (10.6 %) or reassurance
and advice (0.0 %) [62, 63]. The most common adverse
event was pain after treatment (19/20 events). However,
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Smidt et al. reported more adverse events for the multi-
modal care group (64 %) compared to corticosteroid in-
jection (58 %) or reassurance and advice (17 %) [66].
The most frequently reported adverse event in all
groups was radiating pain to the forearm or upper
arm, followed by increased pain lasting greater than
one day, and increased pain lasting less than one day.
Discussion
Summary of evidence
We conducted a systematic review to evaluate the effect-
iveness of multimodal care for the management of mus-
culoskeletal disorders of the elbow, forearm, wrist and
hand. Overall, we identified one multimodal program of
care for the management of persistent CTS. The best
evidence suggests that multimodal care (NSAIDs, educa-
tion booklet, exercise, stretching, splint, ultrasound,
home/workplace modifications) was not as effective as
decompression surgery and hand therapy for reduction
of symptom severity [61].
Our review suggests that there may be a role for
multimodal care in the management of patients with
persistent lateral epicondylitis. Specifically, we found
that multimodal care was more effective in the long-
term, than corticosteroid injection but was equally effect-
ive to reassurance and advice [62, 63, 66]. Our synthesis
also suggests that education, exercise (strengthening,
stretching, occupational exercise), manual therapy (ma-
nipulation) and soft tissue therapy (massage) are common
components included in a multimodal care of care associ-
ated with superior outcomes for the management of
lateral epicondylitis [62, 63, 65, 66]. On average, the inten-
sity of multimodal care associated with superior outcomes
included five visits offered over a five week period.
Other systematic reviews
Systematic reviews that focus on the effectiveness of
multimodal care are uncommon. We did not identify
previous systematic reviews that specifically examined
the effect of multimodal care for musculoskeletal disor-
ders of the elbow, forearm, wrist and hand. However
previous reviews combined the results of multimodal
care with those of single interventions. Page et al. and
Huisstede et al., reported that there is limited and very
low quality evidence for combining exercise, splint and
mobilisation interventions for the management of CTS
[21, 74]. Further, Huisstede et al. concluded that there
was no evidence for the effectiveness of chiropractic
therapy which included manual therapy, massage, ultra-
sound, and a splint [21]. Two recent systematic reviews
of lateral epicondylitis support our finding that exercise
should be included as part of a multimodal program of
care [75, 76]. However, these reviews had important lim-
itations which included basing conclusions on studies
with small sample sizes [21, 74–76] and not accounting
for clustering in their analysis resulting in a unit of ana-
lysis error [21, 74].
Strengths and limitations
Our systematic review has strengths. First, we developed
a sensitive search strategy which was peer reviewed by a
second librarian to minimize errors. Second, we used
the Scottish Intercollegiate Guidelines Network (SIGN)
criteria to ensure standardization of the critical appraisal
process. We contacted authors to obtain further infor-
mation in relation to study design. Finally, our conclu-
sions are based on the best-evidence synthesis method
to minimize the risk of bias associated with using low
quality studies [44, 49].
Some limitations are noted in our review. First, we
restricted our search to include articles in the English
language, which may have excluded some relevant stud-
ies. However, other systematic reviews of clinical trials
have also limited their search to the English language
and this did not lead to biased results [77]. Other sys-
tematic reviews reported similar results when studying
the effect of language-restrictions in conventional medi-
cine [78–80]. Second, multimodal care is not a universally
accepted search term in the rehabilitation literature.
Although rehabilitation study interventions frequently
include more than a single treatment modality, this
information is often not clearly identified as a key
word or presented in the study abstract. Thus, some
studies, which employed multimodal interventions,
may have been overlooked. Therefore, it is important
that future trials of multimodal intervention correctly
identify their interventions as multimodal. Third, the
number of combinations of modalities in a multi-
modal program of care has no theoretical limit. This
review reports on those combinations of modalities
examined in the current literature. Future research of
multimodal care should focus on multimodal pro-
grams of care which include modalities with demon-
strated effectiveness. Fourth, we did not review
qualitative studies exploring the lived experience of
patients receiving multimodal care. We are therefore
unable to comment on how patients valued and expe-
rienced their exposure to multimodal interventions.
Although this is not a source of bias in our review, it
is recommended that future systematic reviews con-
sider examining qualitative studies to gain insight into
the patients’ perspective of multimodal care. Finally,
the reviewed studies were heterogeneous with respect
to multimodal programs of care, outcomes measured
and follow-up time points. This level of clinical het-
erogeneity did not allow pooling of results across
studies through meta-analysis.
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Future research
Clinicians often combine modalities in a program of
multimodal care, but little research is available to inform
the best combination of modalities. Future research of
multimodal programs of care should begin from the
premise that only evidence-based modalities for the
management of the musculoskeletal disorder of interest
should be included in a defined program of care. Fur-
ther, it is recommended that comparison groups which
include the full program of multimodal care less one
modality should be employed to ascertain the best com-
bination of modalities. This systematic review identified
low risk of bias studies examining persistent CTS and
lateral epicondylitis. Research examining recent onset
CTS and lateral epicondylitis are required to inform
their management. Further, studies that address the
effectiveness of multimodal care for the management of
other musculoskeletal disorders of the elbow, forearm,
wrist and hand are needed.
Conclusions
Multimodal care reflects the combination of therapeutic
interventions that are used by health care providers to
manage patients with musculoskeletal disorders of the
elbow, forearm, wrist and hand. Multimodal care for the
management of persistent lateral epicondylitis may in-
clude education, exercise (strengthening, stretching,
occupational exercise), manual therapy (manipulation)
and soft tissue therapy (massage). The evidence did not
support the use of multimodal care for the management
of carpal tunnel syndrome. We did not identify low risk
of bias studies for the management of other musculo-
skeletal disorders. Our systematic review highlights the
need for further high quality studies to determine the
effectiveness of multimodal care for musculoskeletal
disorders of the elbow, forearm, wrist and hand.
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